Lecanemab Gains FDA Approval for Early Alzheimer Disease

被引:57
|
作者
Larkin, Howard D. D.
机构
来源
关键词
D O I
10.1001/jama.2022.24490
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:363 / 363
页数:1
相关论文
共 50 条
  • [21] Lecanemab, a Novel Amyloid ß-Directed Antibody for Early Alzheimer Disease
    Toderika, Yuliana
    Najib, Jadwiga
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2023, 19 (09):
  • [22] Lecanemab: A Humanized Monoclonal Antibody for the Treatment of Early Alzheimer Disease
    Park, Juliane
    Simpson, Carson
    Patel, Katie
    ANNALS OF PHARMACOTHERAPY, 2024, 58 (10) : 1045 - 1053
  • [23] Lecanemab for Alzheimer Disease: Is It Worth It?
    Nelson, Sarah E.
    Lopez, Oscar L.
    NEUROLOGY, 2024, 102 (07)
  • [24] Ceritinib Gains FDA Approval for Lung Cancer
    不详
    CANCER DISCOVERY, 2014, 4 (07) : 753 - 754
  • [25] Controversy and Progress in Alzheimer's Disease - FDA Approval of Aducanumab
    Rabinovici, Gil D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (09): : 771 - 774
  • [26] US FDA defends approval of Alzheimer's disease drug
    Jaffe, Susan
    LANCET, 2021, 398 (10294): : 12 - 12
  • [27] Approval of Aducanumab for Alzheimer Disease-the FDA's Perspective
    Dunn, Billy
    Stein, Peter
    Cavazzoni, Patrizia
    JAMA INTERNAL MEDICINE, 2021, 181 (10) : 1276 - 1278
  • [28] FDA issues Aricept® approval for severe Alzheimer's disease
    不详
    PSYCHOPHARMAKOTHERAPIE, 2007, 14 (01): : X - X
  • [29] Surgical sealant gains FDA approval to market
    不详
    ADHESIVES AGE, 2001, 44 (09): : 7 - 7
  • [30] Chocolate ballon catheter gains FDA approval
    Fitzpatrick, Sean
    EXPERT REVIEW OF MEDICAL DEVICES, 2012, 9 (02) : 103 - 103